Kezar Life Sciences
127 hedge funds and large institutions have $442M invested in Kezar Life Sciences in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.24% more ownership
Funds ownership: 7.85% → 9.09% (+1.2%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
40% less capital invested
Capital invested by funds: $734M → $442M (-$292M)
Holders
127
Holding in Top 10
4
Calls
$33.7M
Puts
$6.72M
Top Buyers
| 1 | +$24.8M | |
| 2 | +$15.1M | |
| 3 | +$12.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$12M |
| 5 |
DM
Deerfield Management
New York
|
+$11.7M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$13.5M | |
| 3 | -$12.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.5M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$9.27M |